{"abstract": "Following results of recent clinical trials on popular cholesterol drugs, cardiologists are questioning whether a patient\u2019s cholesterol should be all that matters.", "web_url": "https://www.nytimes.com/2008/01/17/business/17drug.html", "snippet": "Following results of recent clinical trials on popular cholesterol drugs, cardiologists are questioning whether a patient\u2019s cholesterol should be all that matters.", "lead_paragraph": "For decades, the theory that lowering cholesterol is always beneficial has been a core principle of cardiology. It has been accepted by doctors and used by drug makers to win quick approval for new medicines to reduce cholesterol.", "print_section": "C", "print_page": "1", "source": "The New York Times", "multimedia": [], "headline": {"main": "New Questions on Treating Cholesterol", "kicker": null, "content_kicker": null, "print_headline": "Cholesterol As a Danger Has Skeptics", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Statins (Cholesterol-Lowering Drugs)", "rank": 1, "major": "N"}, {"name": "organizations", "value": "Merck & Company Inc", "rank": 2, "major": "N"}, {"name": "subject", "value": "Cholesterol", "rank": 3, "major": "N"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 4, "major": "N"}, {"name": "subject", "value": "Zetia (Drug)", "rank": 5, "major": "N"}, {"name": "organizations", "value": "AMERICAN HEART ASSN", "rank": 6, "major": "N"}], "pub_date": "2008-01-17T05:00:00+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Alex Berenson", "person": [{"firstname": "Alex", "middlename": null, "lastname": "Berenson", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/569bbbb7-d9f0-5e08-a31e-e7fc24461547", "word_count": 1009, "uri": "nyt://article/569bbbb7-d9f0-5e08-a31e-e7fc24461547"}